Polymeric nanoparticles for dopamine and levodopa replacement in Parkinson's disease-Reference-Cited by-同舟云学术

Polymeric nanoparticles for dopamine and levodopa replacement in Parkinson's disease

Published:2022 Issue:24 Volume:4 Page:5233-5244
ISSN:2516-0230
Container-title:Nanoscale Advances
language:en
Short-container-title:Nanoscale Adv.

Author:

Alabrahim Obaydah Abd Alkader¹^ORCID,Azzazy Hassan Mohamed El-Said²³^ORCID

Affiliation:

1. Graduate Nanotechnology Program, School of Sciences & Engineering, The American University in Cairo, 11835 New Cairo, Egypt

2. Department of Chemistry, School of Sciences & Engineering, The American University in Cairo, AUC Avenue, P. O. Box 74, New Cairo 11835, Egypt

3. Department of Nanobiophotonics, Leibniz Institute for Photonic Technology, Albert Einstein Str. 9, Jena 07745, Germany

Abstract

This review focuses on the recent polymeric nanoparticulate drug delivery systems that have been exploited for dopamine and levodopa replacement in Parkinson's disease.

Funder

American University in Cairo

Publisher

Royal Society of Chemistry (RSC)

Subject

General Engineering,General Materials Science,General Chemistry,Atomic and Molecular Physics, and Optics,Bioengineering

Link

http://pubs.rsc.org/en/content/articlepdf/2022/NA/D2NA00524G

Reference69 articles.

1. Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

2. Evaluation of Models of Parkinson's Disease

3. Parkinson's disease: Autoimmunity and neuroinflammation

4. Neuroprotective effects of indole-3-carbinol on the rotenone rat model of Parkinson's disease: Impact of the SIRT1-AMPK signaling pathway

5. Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation and application of boron and fluorine co-doped rGO electrochemical sensor;Journal of the Indian Chemical Society;2024-10

2. Recognition of monoamine neurotransmitters by cucurbiturils;Computational and Theoretical Chemistry;2024-09

3. Advances in Brain Stimulation, Nanomedicine and the Use of Magnetoelectric Nanoparticles: Dopaminergic Alterations and Their Role in Neurodegeneration and Drug Addiction;Molecules;2024-07-29

4. Tricompartmental Microcarriers with Controlled Release for Efficient Management of Parkinson’s Disease;ACS Biomaterials Science & Engineering;2024-07-09

5. Dopamine-loaded chitosan-coated solid lipid nanoparticles as a promise nanocarriers to the CNS;Neuropharmacology;2024-05